The long-awaited translation of stem cell–based therapies to the clinic requires engineering approaches.
No takes yet. Share an insight, caveat, or question.
Healy et al. (2013) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: